Storys zum Thema Pharmakologie

STADA Arzneimittel AG

Press release: Alvotech and STADA add to strategic alliance through denosumab partnership

Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...

STADA Arzneimittel AG

Press release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo

STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK

Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...

PNO Innovation GmbH

canSERV invites applications for "Revolutionising Cancer Patient Care"

PNO Innovation GmbH

3

canSERV invites applications for "Revolutionising Cancer Patient Care"

STADA Arzneimittel AG

Press release: STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey

STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey - Total carbon emissions by STADA reduced by 25% between 2020 and 2023 - Around 45% of STADA’s electricity consumption now comes from renewable ...

Gerresheimer AG

2

Gerresheimer partners with RxCap to offer connected adherence solutions

Bosch Healthcare Solutions GmbH

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform

Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. - PCR test for multiresistant gram-negative (MRGN) ...

Dr. Reddy's Laboratories SA

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment

Norgine GmbH

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...

STADA Arzneimittel AG

Press release: STADA continues with double-digit sales and profit growth in 2023

RHEACELL GmbH und Co. KG

Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘

LTS Lohmann Therapie-Systeme AG

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

Helmholtz Munich

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Acousia Therapeutics GmbH

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...

Biomay AG

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service

STADA Arzneimittel AG

Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...

STADA Arzneimittel AG

Press release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

Acousia Therapeutics GmbH

Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...

LTS Lohmann Therapie-Systeme AG

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

LTS Lohmann Therapie-Systeme AG

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

Fraunhofer-Institut für Produktionstechnologie IPT

Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems